Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
In mice, periodic cycles of a fasting mimicking diet (FMD) protect normal cells while killing damaged cells including cancer and autoimmune cells, reduce inflammation, promote multi-system regeneration, and extend longevity. Here, we performed secondary and exploratory analysis of blood samples from a randomized clinical trial (NCT02158897) and show that 3 FMD cycles in adult study participants are associated with reduced insulin resistance and other pre-diabetes markers, lower hepatic fat (as determined by magnetic resonance imaging) and increased lymphoid to myeloid ratio: an indicator of immune system age. Based on a validated measure of biological age predictive of morbidity and mortality, 3 FMD cycles were associated with a decrease of 2.5 years in median biological age, independent of weight loss. Nearly identical findings resulted from a second clinical study (NCT04150159). Together these results provide initial support for beneficial effects of the FMD on multiple cardiometabolic risk factors and biomarkers of biological age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NCT05805319 aims to improve dietary fiber intake among NSCLC patients to increase SCFAs, while the fasting mimicking diet for reducing immune related adverse events for cancer patients on immune checkpoint inhibitors (“FMD-ICI Trial,” NCT06438588) is investigating the effect of a proprietary blend (Xentigen) that mimics periodic fasting (Brandhorst et al., 2024) on the occurrence of irAEs.”
From Microbiota-centered interventions to boost immune checkpoint blockade therapies (2025) · cites this paper as Brandhorst et al., 2024
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 2×
“Here, we used the homeostatic model assessment to measure insulin resistance (HOMA-IR) 39 prior to and after completion of the third FMD cycle in pre-diabetic study participants.”
InfluentialToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
An epigenetic biomarker of aging for lifespan and healthspan
Levine, M. E., Lu, A. T., Quach, A., Chen, B. H., Assimes, T. L., Bandinelli, S., Hou, L., Baccarelli, A. A., Stewart, J. D., Li, Y., et al. (2018) · Aging · doi:10.18632/aging.101414 · Cited by 3,675
Self-citationLean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Effects of intermittent fasting on health, aging, and disease
de Cabo, R., & Mattson, M. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1905136 · Cited by 1,605
Fasting: molecular mechanisms and clinical applications
Longo, V. D., & Mattson, M. P. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.008 · Cited by 1,425 · cited 1×
“…ts in preclinical studies such as weight loss, improved insulin sensitivity, autophagy activation, cell renewal, and anti-cancer effects, but is associated with some safety and compliance concerns which may be responsible for the limited contribution of PF to standard medical practice 15,21 – 29 .”
Self-citationInfluence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000094221.86888.ae · Cited by 1,391
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062 · cited 1×
“…fatty liver disease, and lower insulin resistance and HbA1c in a small subset of study participants which builds on our previous clinical and pre-clinical results to indicate that FMD cycles help prevent and can be considered as a therapy to prevent metabolic syndromeand diabetes 2,57 .”
Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan
Longo, V. D., & Panda, S. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.001 · Cited by 1,013 · cited 3×
“Everyday nutrition and particularly protein as well as carbohydrate levels and sources are known to play a pivotal role in accelerating the aging process and mortality in rodents and possibly humans 15 – 17 .”
Self-citation
Cited by
Lyu, Y.-X., Fu, Q., Wilczok, D., Ying, K., King, A., Antebi, A., Vojta, A., Stolzing, A., Moskalev, A., Georgievskaya, A., et al. (2024) · Aging · doi:10.18632/aging.206135 · Cited by 74
The Gut‒Liver Axis in Liver Disease: Molecular Mechanisms and Therapeutic Targets
Chen, Z., Liao, S., Wu, S., Chen, S., Tang, Q., Zhou, L., Li, X., Hu, H., Xu, J., Zhang, A., et al. (2025) · MedComm · doi:10.1002/mco2.70458 · Cited by 34
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Basu, R., Boguszewski, C. L., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae030 · Cited by 28
Microbiota-centered interventions to boost immune checkpoint blockade therapies
Almonte, A. A., Thomas, S., & Zitvogel, L. (2025) · Journal of Experimental Medicine · doi:10.1084/jem.20250378 · Cited by 19
Biţă, A., Scorei, I. R., Soriano-Ursua, M. A., Mogoşanu, G. D., Belu, I., Ciocîlteu, M. V., Biță, C. E., Rău, G., Pisoschi, C. G., Racu, M.-V., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18060766 · Cited by 16
“Recent scientific findings also highlight the link between healthy gut symbiosis and reduced IGF-1 levels [90].”
Metadata
- Authors
- Brandhorst, S., Levine, M. E., Wei, M., Shelehchi, M., Morgan, T. E., Nayak, K. S., Dorff, T., Hong, K., Crimmins, E. M., Cohen, P., & Longo, V. D.
- Affiliations
- University of Southern California (US)
- Yale University (US)
- Corresponding author
- Longo, Valter D.
- ORCID
- Venue
- Nature Communications
- Published
- 2024-02-20
- Volume
- 15
- Issue
- 1
- Pages
- 1309-1309
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC10879164
- OpenAlex
- W4391960344
- Cited by
- 71
- References
- 68
- Citations by year
- 2026: 31 · 2025: 29 · 2024: 11
- FWCI
- 20.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Southern California: Edna Jones Chair Fund
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (1R01AG060110-01)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- fasting-mimicking diet, biological age, insulin resistance, prediabetes, liver fat, immunosenescence, cardiometabolic risk factors, blood biomarkers, weight loss, longevity
- MeSH terms
- Adult, Animals, Child, Preschool, Diet, Fasting, Humans, Liver, Longevity, Causality, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk. https://app.cochat.ai/papers/10.1038/s41467-024-45260-9
- The paper
- Brandhorst, S., Levine, M. E., Wei, M., Shelehchi, M., Morgan, T. E., Nayak, K. S., Dorff, T., Hong, K., Crimmins, E. M., Cohen, P., & Longo, V. D. (2024). Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk. Nature Communications. https://doi.org/10.1038/s41467-024-45260-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.